Daehan New Pharm Co., Ltd. engages in the manufacture and sale of pharmaceuticals, herbals, health supplements, and veterinary medicines in South Korea. The company’s pharmaceutical products include analgesics, anti-inflammatory drugs, antipyretics, antibacterials, antidiabetics, antineoplastics and immunosuppressants, cardiovascular drugs, gastrointestinal drugs, muscle relaxants, antispasmodics, creams/ointments, and others. Its animal health products comprise antibacterials, coccidiostats and antihelmintics, probiotics, nutrients, metabolic stimulants, disinfectants, insecticides, functional supplement feed, and liver tonics for poultry, cattle, sheep, swine, and fish. The company also offers health foods and functional beverages; and markets baby care products. It exports antineoplastics, antibiotics, trombolytics, vasodilators, ntihistamins, and antidiabetics to Southeast and Southwest Asia, the Middle East, South America, and Africa; and supplies feed additives and ethical medicines to Pakistan. The company provides its products in various forms, such as tablets, capsules, granules, powder, creams, unguents, vials, and ampoules. Daehan New Pharm Co., Ltd. was founded in 1984 and is headquartered in Seoul, South Korea.
daehan new pharm co ltd (054670:KOSDAQ)
Phone: 82 2 3415 7815
Fax: 82 2 581 2333www.dhnp.co.kr/eng/default.htm
|No competitor information is available for 054670.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact DAEHAN NEW PHARM CO LTD, please visit www.dhnp.co.kr/eng/default.htm. Company data is provided by Capital IQ. Please use this form to report any data issues.